Method of preparing microsphere of ethoxyl copolymer PLGA in interferon poly acid

A technology of polylactic acid and interferon, applied in medical preparations with non-active ingredients, medical preparations containing active ingredients, drug combinations, etc., can solve the problems of short biological half-life, poor stability, hindering use, etc., and achieve smooth surface , Good fluidity, prolonging the effect of action time

Inactive Publication Date: 2007-04-04
SUN YAT SEN UNIV
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the short biological half-life and poor stability of peptide and protein drugs, they are easily metabolized by enzymes in the body and difficult to abs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method of preparing microsphere of ethoxyl copolymer PLGA in interferon poly acid
  • Method of preparing microsphere of ethoxyl copolymer PLGA in interferon poly acid

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0025] Example 1 Preparation of interferon polylactic acid-glycolic acid copolymer (PLGA) microspheres

[0026] (1) Preparation of polylactic acid-glycolic acid copolymer (PLGA) solution

[0027] 400 mg of polylactic acid-glycolic acid copolymer (PLGA) was dissolved in 2 ml of dichloromethane to form an organic phase (20% g / ml).

[0028] (2) Preparation of interferon PBS solution

[0029] Dissolve 40 mg of lyophilized recombinant human interferon-α for injection in 300 μl of 1% (g / ml) gelatin solution to form an internal aqueous phase;

[0030] (3) Preparation of colostrum

[0031] Inject the internal water phase into the organic phase, stir and emulsify for 1 minute at 9000 rpm to form colostrum (W / O);

[0032] (4) Preparation of double emulsion

[0033] Add the colostrum to 300ml solution (outer water phase) containing 1% (g / ml) PVA and 1% (g / ml) NaCl under stirring at 2000 rpm, emulsify for 10 minutes, and emulsify into double emulsion (W / O / W);

[0034] (5) Formation of micros...

Example Embodiment

[0039] Example 2 Preparation of interferon polylactic acid-glycolic acid copolymer (PLGA) microspheres

[0040] (1) Preparation of polylactic acid-glycolic acid copolymer (PLGA) solution

[0041] 600 mg of polylactic acid-glycolic acid copolymer (PLGA) was dissolved in 2 ml of dichloromethane to form an organic phase (30% g / ml).

[0042] (2) Preparation of interferon PBS solution

[0043] Dissolve 60 mg of freeze-dried recombinant human interferon-α for injection in 300 μl of 30% PEG400 solution to form an internal aqueous phase;

[0044] (3) Preparation of colostrum

[0045] Inject the internal water phase into the organic phase, stir and emulsify for 3 minutes at 1000 rpm to form colostrum (W / O);

[0046] (4) Preparation of double emulsion

[0047] Add the colostrum to 200ml containing 3% (g / ml) PVA and 0.5% (g / ml) NaCl solution (outer water phase) under stirring at 1600rpm, emulsify for 20 minutes, and emulsify into double emulsion (W / O / W);

[0048] (5) Formation of microspher...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Concentrationaaaaaaaaaa
The average particle sizeaaaaaaaaaa
The average particle sizeaaaaaaaaaa
Login to view more

Abstract

A microspherical interferon polylactate-glycollate copolymer (PLGA) is prepared from the polylactate-glycollate copolymer (PLGA) as microspherical carrier and the recombinant human interferon-alpha as the coated object by remulsifying-solvent evaporating method.

Description

technical field [0001] The invention relates to a method for preparing biodegradable controlled-release microspheres of bioactive drugs, and belongs to the field of cross research between biomedical polymer materials and controlled-release preparations of bioactive drugs. Background technique [0002] In recent years, with the rapid development of biotechnology, more and more peptide and protein drugs have been developed, and have shown many unique curative effects in clinical applications, such as insulin, hepatitis B vaccine, interferon, etc. However, due to the short biological half-life and poor stability of peptide and protein drugs, they are easily metabolized by enzymes in the body and difficult to absorb in the gastrointestinal tract, so long-term and frequent injections are required, which hinders their convenient, extensive and effective clinical application. use. [0003] Recombinant human interferon-α is a product prepared by biotechnology. It is a milky white p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/21A61K9/14A61K47/34A61P37/02A61P35/00A61P31/12
Inventor 徐安龙杨帆高建萍赵耀明王磊董美玲
Owner SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products